That's really unfortunate.
This Liberal government spent $19 billion—that's “billion” with a B—on consultants last year alone. Those consultants aren't doing any research, most likely. At least, it's not the groundbreaking work the folks at BioCanRx are doing.
You talked about clinical trials. Can you quantify the downstream impact that these funding cuts could have on patients, particularly those who rely on the clinical trials or emerging therapies that BioCanRx helps support?
